Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.19
+0.15 (+0.60%)
Official Closing Price
Updated: 7:00 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
99
100
Next >
Why Is Repligen (RGEN) Stock Soaring Today
October 01, 2025
Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 6.6% in the afternoon session after HSBC initiated coverage on the stock with a 'Buy' rating and a $150 price...
Via
StockStory
Topics
Government
Stock Of The Day: Will Pfizer Head Higher?
↗
October 01, 2025
Pfizer (PFE) shares may have broken out. This means a large amount of supply has come off the market. This is bullish.
Via
Benzinga
Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to Know
↗
October 01, 2025
Pfizer's CEO says the deal with the Trump administration is "a win" for the company. He's probably right.
Via
The Motley Fool
Topics
Government
World Trade
Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away
↗
October 01, 2025
Pfizer's deal with TrumpRx for steep drug discounts could impact UnitedHealth, Eli Lilly, and CVS. Here's how...
Via
Benzinga
Pfizer India Rises On Trump’s Drug Discount Deal — SEBI Analyst Eyes Breakout Above ₹5,300
↗
October 01, 2025
Via
Stocktwits
Topics
Government
Indian Markets Open Firm Ahead Of RBI Policy; Tata Investment, Pfizer, Shriram Finance Gain Ground
↗
October 01, 2025
Via
Stocktwits
FTSE 100 Soars to All-Time High Amidst US Government Shutdown Concerns
October 01, 2025
London's benchmark FTSE 100 index (LSE: UKX) defied global headwinds on October 1, 2025, surging to an unprecedented intraday record high of 9,423.24 points. This landmark achievement underscores a...
Via
MarketMinute
Topics
Economy
Government
World Trade
U.S. Labor Market Takes a Dive: ADP Report Signals Significant Weakening and Fuels Rate Cut Expectations
October 01, 2025
The U.S. private sector labor market unexpectedly shed 32,000 jobs in September 2025, according to the latest ADP National Employment Report released on October 1, 2025. This surprising downturn...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
US Government Shutdown Ignites Market Volatility and Economic Uncertainty
October 01, 2025
As the United States government enters a shutdown as of October 1, 2025, financial markets are bracing for a fresh wave of economic uncertainty and volatility. This immediate "risk-off" environment has...
Via
MarketMinute
Topics
Economy
Government
Stocks
Mark Cuban Grades Trump's Online Drug Store 'B,' Plans To Give It An 'A' If These Changes Happen: 'Trump Gets All The Credit'
↗
October 01, 2025
Mark Cuban, the billionaire entrepreneur and investor, has given a cautious "B" grade to President Donald Trump's new online drug store venture, TrumpRx.gov.
Via
Benzinga
Topics
Government
Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff
↗
October 01, 2025
Drug stocks are celebrating in the wake of Trump's threat to levy a 100% tariff on pharmaceutical imports starting Wednesday.
Via
Investor's Business Daily
Topics
Economy
Government
World Trade
Banking Rally Lifts Indian Markets: RBI Policy Boosts Nifty To 24,800, Sensex Ends Near 81,000
↗
October 01, 2025
Benchmarks staged a strong comeback on RBI’s supportive policy measures, though retail sentiment on Nifty 50 remained ‘bearish’ on Stocktwits.
Via
Stocktwits
Topics
Economy
Government
Better AI Dividend Stock: Apple vs. Broadcom
↗
October 01, 2025
These two AI titans have started paying dividends. Which is the better stock for dividend investors?
Via
The Motley Fool
Topics
Artificial Intelligence
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
↗
October 01, 2025
These stocks could see growth take off over the next few years.
Via
The Motley Fool
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9.5% -- Which Are No-Brainer Buys in October
↗
October 01, 2025
Three supercharged income stocks have the catalysts necessary to pad the pocketbooks of patient investors.
Via
The Motley Fool
U.S. Government Shut Down: Navigating the Fiscal Precipice on October 1, 2025
October 01, 2025
As of October 1, 2025, the United States federal government has entered a state of shutdown, marking the first such occurrence since 2018-2019. This fiscal impasse, triggered by Congress's failure to...
Via
MarketMinute
Topics
Bonds
Economy
Immigration
Wall Street Climbs Despite Shutdown Risk — Pfizer and CoreWeave Shine Bright
↗
October 01, 2025
Markets closed in the green on Tuesday, undeterred by the looming U.S. government shutdown. Pfizer surged nearly 7% on a political deal, while CoreWeave soared after signing a multibillion-dollar AI...
Via
Chartmill
Topics
Artificial Intelligence
3 Cash-Producing Stocks We Keep Off Our Radar
October 01, 2025
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...
Via
StockStory
3 Reasons PFE is Risky and 1 Stock to Buy Instead
October 01, 2025
Pfizer has been treading water for the past six months, recording a small return of 3.6% while holding steady at $25.42. The stock also fell short of the S&P 500’s 18.8% gain during that period.
Via
StockStory
Topics
Stocks
Sensex, Nifty Poised For Quiet Start; Pfizer, Lupin, Tata Motors, RateGain, Newgen, RITES On Stock Watchlist
↗
September 30, 2025
Via
Stocktwits
Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma
↗
September 30, 2025
Via
Stocktwits
Topics
Government
Lithium Americas, Nike, Pfizer, CoreWeave And Occidental Petroleum: Why These 5 Stocks Are On Investors' Radars Today
↗
September 30, 2025
The U.S. stock market brushed aside worries over a potential government shutdown and advanced on Tuesday. The Dow Jones Industrial Average gained nearly 0.2% to 46,397.89.
Via
Benzinga
Topics
Stocks
Stock Market Today: Pfizer Rallies on Trump Drug Pricing Deal and U.S. Investment Pledge
↗
September 30, 2025
Pfizer surged after striking a landmark agreement with the Trump administration to lower drug prices and expand U.S. production.
Via
The Motley Fool
Topics
Government
Stocks
World Trade
Gold Poised for Record Highs Above US$3,860 as U.S. Government Shutdown Looms, Igniting Safe-Haven Rush
September 30, 2025
As the U.S. government shutdown deadline looms on September 30, 2025, financial markets are bracing for impact, with gold prices exhibiting strong upward momentum, driven by intense safe-haven demand....
Via
MarketMinute
Topics
Bonds
Economy
Global Markets Defy Headwinds: Resilient Sentiment Prevails Despite Shutdown Fears
September 30, 2025
As the third quarter of 2025 drew to a close on September 30, global financial markets demonstrated a remarkable display of resilience, largely shrugging off significant geopolitical uncertainties and...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector
September 30, 2025
The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Global Markets Brace for US Government Shutdown: A Deep Dive into Investor Jitters and Currency Swings
September 30, 2025
As September 2025 draws to a close, a palpable sense of unease has settled over global financial markets, triggered by the looming specter of a U.S. government shutdown. While Wall Street indices...
Via
MarketMinute
Topics
Economy
Stocks
World Trade
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
CoreWeave's Sudden Plunge: A Reality Check for the High-Flying AI Infrastructure Market
September 30, 2025
Today's market close saw an unexpected and significant downturn for CoreWeave (NASDAQ: CRWV), the specialized AI cloud provider, marking it as one of the day's bottom performers. This abrupt reversal...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Pfizer Plummets as Key Obesity Drug Candidate Faces Major Setback, Shaking Investor Confidence
September 30, 2025
New York, NY – September 30, 2025 – Shares of pharmaceutical giant Pfizer (NYSE: PFE) experienced a dramatic decline today, making it one of the market's bottom performers, following an unexpected and...
Via
MarketMinute
Topics
Intellectual Property
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today